| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$162,038,028 |
|
|
|
Indirect Value
|
$374,282,250 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$536,320,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2014-03-27 |
4 |
B |
$25.72 |
$6,249,986 |
I/I |
243,001 |
243,001 |
2.64 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-23 |
4 |
S |
$18.48 |
$4,644,671 |
I/I |
(251,335) |
2,280,894 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-06 |
4 |
B |
$5.23 |
$1,364,575 |
I/I |
260,913 |
156,212 |
2.64 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-08-10 |
4 |
B |
$6.13 |
$1,604,031 |
I/I |
261,669 |
1,000,000 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2012-05-17 |
4 |
B |
$7.50 |
$2,242,553 |
I/I |
299,007 |
3,977,445 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-20 |
4 |
B |
$4.63 |
$1,396,732 |
I/I |
301,670 |
918,459 |
2.64 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-14 |
4 |
S |
$17.36 |
$5,262,996 |
I/I |
(303,168) |
3,096,119 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2005-11-17 |
4 |
A |
$19.56 |
$6,000,014 |
I/I |
306,710 |
102,236 |
|
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-30 |
4 |
B |
$4.79 |
$1,473,366 |
I/I |
307,592 |
153,706 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2021-11-19 |
4 |
B |
$3.75 |
$1,153,729 |
I/I |
307,661 |
307,661 |
2.25 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-07 |
4 |
B |
$5.55 |
$1,865,910 |
I/I |
336,200 |
1,182,000 |
1.5 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2014-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
344,258 |
58,800 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2012-05-16 |
4 |
B |
$7.44 |
$2,566,130 |
I/I |
344,910 |
3,678,438 |
2.25 |
- |
|
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2017-06-29 |
4 |
A |
$0.00 |
$5,289,450 |
I/I |
359,785 |
27,651 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-06-13 |
4 |
A |
$16.27 |
$5,999,996 |
I/I |
368,720 |
429,912 |
|
- |
|
| PGEN |
Precigen Inc |
|
• • • |
2023-08-15 |
4 |
B |
$1.50 |
$577,301 |
I/I |
380,589 |
31,718,375 |
0.01 |
% |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2018-11-20 |
4 |
A |
$0.00 |
$0 |
I/I |
396,668 |
83,221 |
0 |
- |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-08-12 |
4 |
B |
$4.26 |
$1,707,689 |
I/I |
400,866 |
220,123 |
2.64 |
% |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-03-20 |
4 |
B |
$2.72 |
$1,143,314 |
I/I |
420,336 |
10,511,973 |
2.64 |
% |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-09-26 |
4 |
A |
$16.50 |
$6,999,997 |
D/D |
424,178 |
2,063,458 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2012-05-15 |
4 |
B |
$7.35 |
$3,142,720 |
I/I |
427,581 |
3,333,528 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-28 |
4 |
S |
$18.02 |
$7,789,127 |
I/I |
(432,249) |
1,897,610 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-20 |
4 |
B |
$4.63 |
$2,095,084 |
I/I |
452,502 |
148,329 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2021-11-23 |
4 |
B |
$3.58 |
$1,741,079 |
I/I |
486,335 |
1,000,000 |
2.25 |
% |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
508,617 |
2,091,141 |
0 |
- |
|
271 Records found
|
|
Page 9 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
